Shekoufeh Nikfar

Author PubWeight™ 68.79‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother 2005 2.84
2 Trend analysis of the pharmaceutical market in Iran; 1997-2010; policy implications for developing countries. Daru 2013 2.56
3 Pesticides and oxidative stress: a review. Med Sci Monit 2004 2.16
4 A meta-analysis on the efficacy and safety of combined vitamin C and E supplementation in preeclamptic women. Hypertens Pregnancy 2009 1.61
5 Efficacy of tricyclic antidepressants in irritable bowel syndrome: a meta-analysis. World J Gastroenterol 2009 1.44
6 Pharmaceutical supply chain risks: a systematic review. Daru 2013 1.44
7 Effects of Satureja khuzestanica on Serum Glucose, Lipids and Markers of Oxidative Stress in Patients with Type 2 Diabetes Mellitus: A Double-Blind Randomized Controlled Trial. Evid Based Complement Alternat Med 2008 1.38
8 Assessment of the vaccine industry in Iran in context of accession to WTO: a survey study. Daru 2012 1.35
9 Patterns of antibiotic consumption in Iran during 2000-2009. Int J Antimicrob Agents 2011 1.34
10 Pharmaceutical market and health system in the Middle Eastern and Central Asian countries: Time for innovations and changes in policies and actions. Arch Med Sci 2011 1.30
11 A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn's disease. Dig Dis Sci 2008 1.26
12 Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am J Obstet Gynecol 2002 1.25
13 A model for developing a decision support system to simulate national drug policy indicators. Arch Med Sci 2011 1.25
14 A systematic review of efficacy and tolerability of mebeverine in irritable bowel syndrome. World J Gastroenterol 2010 1.19
15 Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials. Clin Ther 2008 1.13
16 Benefits of Zataria multiflora Boiss in Experimental Model of Mouse Inflammatory Bowel Disease. Evid Based Complement Alternat Med 2006 1.11
17 Increased morbidity and mortality in acute human organophosphate-poisoned patients treated by oximes: a meta-analysis of clinical trials. Hum Exp Toxicol 2006 1.11
18 A meta-analysis of broad-spectrum antibiotic therapy in patients with active Crohn's disease. Clin Ther 2006 1.10
19 Reduction of diabetes-induced oxidative stress by phosphodiesterase inhibitors in rats. Comp Biochem Physiol C Toxicol Pharmacol 2005 1.10
20 The place of antibiotics in management of irritable bowel syndrome: a systematic review and meta-analysis. Arch Med Sci 2010 1.10
21 Effect of Satureja khuzestanica essential oil on male rat fertility. Fitoterapia 2006 1.08
22 Effects of aspirin consumption during pregnancy on pregnancy outcomes: meta-analysis. Birth Defects Res B Dev Reprod Toxicol 2003 1.08
23 Biochemical and histopathological evidences for beneficial effects of satureja khuzestanica jamzad essential oil on the mouse model of inflammatory bowel diseases. Toxicol Mech Methods 2006 1.06
24 Efficacy and tolerability of Hypericum perforatum in major depressive disorder in comparison with selective serotonin reuptake inhibitors: a meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 2008 1.04
25 On the benefit of probiotics in the management of pouchitis in patients underwent ileal pouch anal anastomosis: a meta-analysis of controlled clinical trials. Dig Dis Sci 2007 1.04
26 Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials. Reprod Toxicol 2006 1.03
27 A meta-analysis and systematic review on the effect of probiotics in acute diarrhea. Inflamm Allergy Drug Targets 2012 1.02
28 Cost-effectiveness analysis review of exemestane in the treatment of primary and advanced breast cancer. Arch Med Sci 2013 1.02
29 Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy--a meta-analysis of 11 randomized controlled trials involving 21,295 participants. Pharmacol Res 2013 1.00
30 Financial perspective of private pharmacies in Tehran (Iran); is it a lucrative business? Daru 2012 1.00
31 A meta-analysis of antibiotic therapy for active ulcerative colitis. Dig Dis Sci 2007 0.99
32 Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis. Reprod Toxicol 2007 0.98
33 A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important? Int J Cardiol 2013 0.98
34 Code of ethics for the national pharmaceutical system: Codifying and compilation. J Res Med Sci 2013 0.97
35 New biologic therapeutics for ulcerative colitis and Crohn's disease. Expert Opin Biol Ther 2014 0.96
36 Do anti-tumor necrosis factors induce response and remission in patients with acute refractory Crohn's disease? A systematic meta-analysis of controlled clinical trials. Biomed Pharmacother 2006 0.95
37 Meta-analysis technique confirms the effectiveness of anti-TNF-alpha in the management of active ulcerative colitis when administered in combination with corticosteroids. Med Sci Monit 2007 0.94
38 A systematic review and meta-analysis of the effects of infliximab on the rate of colectomy and post-operative complications in patients with inflammatory bowel disease. Arch Med Sci 2011 0.93
39 A systematic review of the safety of probiotics. Expert Opin Drug Saf 2014 0.92
40 Nivolumab and pembrolizumab as immune-modulating monoclonal antibodies targeting the PD-1 receptor to treat melanoma. Expert Rev Anticancer Ther 2015 0.91
41 Cost-effectiveness of adding-on new antiepileptic drugs to conventional regimens in controlling intractable seizures in children. Daru 2012 0.86
42 Antioxidant therapy in the management of acute, chronic and post-ERCP pancreatitis: a systematic review. World J Gastroenterol 2009 0.85
43 Effect of chromium on glucose and lipid profiles in patients with type 2 diabetes; a meta-analysis review of randomized trials. J Pharm Pharm Sci 2013 0.85
44 The effects of statins on blood pressure in normotensive or hypertensive subjects--a meta-analysis of randomized controlled trials. Int J Cardiol 2013 0.85
45 Alterations in salivary antioxidants, nitric oxide, and transforming growth factor-beta 1 in relation to disease activity in Crohn's disease patients. Ann N Y Acad Sci 2006 0.85
46 Comparison of mesalazine and balsalazide in induction and maintenance of remission in patients with ulcerative colitis: a meta-analysis. Dig Dis Sci 2008 0.84
47 Induction of clinical response and remission of inflammatory bowel disease by use of herbal medicines: a meta-analysis. World J Gastroenterol 2013 0.84
48 Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trials. Curr Med Res Opin 2013 0.83
49 A system dynamics model for national drug policy. Daru 2014 0.83
50 Metabolic and toxicological considerations for the latest drugs used to treat irritable bowel syndrome. Expert Opin Drug Metab Toxicol 2013 0.82
51 Benefit of nanocarrier of magnetic magnesium in rat malathion-induced toxicity and cardiac failure using non-invasive monitoring of electrocardiogram and blood pressure. Toxicol Ind Health 2011 0.82
52 Study on the correlations among disease activity index and salivary transforming growth factor-beta 1 and nitric oxide in ulcerative colitis patients. Ann N Y Acad Sci 2007 0.82
53 Ranibizumab and aflibercept for the treatment of wet age-related macular degeneration. Expert Opin Biol Ther 2015 0.82
54 Influence of ascorbic acid supplementation on type 2 diabetes mellitus in observational and randomized controlled trials; a systematic review with meta-analysis. J Pharm Pharm Sci 2014 0.81
55 Are probiotics effective in management of irritable bowel syndrome? Arch Med Sci 2012 0.80
56 Commercialization of biopharmaceutical knowledge in Iran; challenges and solutions. Daru 2014 0.80
57 A systematic review of drugs in late-stage development for the treatment of multiple sclerosis: a focus on oral synthetic drugs. Inflamm Allergy Drug Targets 2015 0.79
58 Prevention of bone resorption by intake of phytoestrogens in postmenopausal women: a meta-analysis. Age (Dordr) 2010 0.79
59 Drug-induced toxic reactions in the eye: an overview. J Infus Nurs 2004 0.79
60 The safety of novel drugs used to treat irritable bowel syndrome. Expert Opin Drug Saf 2014 0.78
61 Stimulatory effects of malathion on the key enzymes activities of insulin secretion in langerhans islets, glutamate dehydrogenase and glucokinase. Toxicol Mech Methods 2006 0.78
62 Phase II drugs under clinical investigation for the treatment of chronic constipation. Expert Opin Investig Drugs 2014 0.78
63 Probiotics use to treat irritable bowel syndrome. Expert Opin Biol Ther 2012 0.77
64 Inflammatory bowel disease therapies discontinued between 2009 and 2014. Expert Opin Investig Drugs 2015 0.76
65 Efficacy and side effects of dacarbazine in comparison with temozolomide in the treatment of malignant melanoma: a meta-analysis consisting of 1314 patients. Melanoma Res 2013 0.75
66 Current opinion on treatment of inflammatory bowel disease in pregnant women. Arch Med Sci 2012 0.75
67 Restoration of morphine-induced alterations in rat submandibular gland function by N-methyl-D-aspartate agonist. Acta Biol Hung 2006 0.75
68 Does Evolocumab, as a PCSK9 Inhibitor, Ameliorate the Lipid Profile in Familial Hypercholesterolemia Patients? A Meta-Analysis of Randomized Controlled Trials. J Pharm Pharm Sci 2017 0.75
69 Prevention by L-arginine/nitric oxide of chlordiazepoxide-induced toxic reactions in the rat salivary gland. Toxicol Mech Methods 2006 0.75
70 A systematic review of the uterine relaxant effect of potassium channel openers. Curr Drug Discov Technol 2013 0.75
71 A Systematic Review of the Uterine Relaxant Effect of Herbal Sources. Curr Pharm Biotechnol 2016 0.75